NDC 83854-002-01 - LACOSAMIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 83854-002
- Requested NDC
- 83854-002-01
- Package NDCs from labels
- 83854-002-01, 83854-002-10
- Manufacturer
- Anthea Pharma Private Limited
- Effective date
- 2026-01-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LACOSAMIDE - Anthea Pharma Private Limited | Anthea Pharma Private Limited | 2026-01-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83854-002-01 | LACOSAMIDE | 20 mL in 1 VIAL | INJECTION, SOLUTION | 20 | 5 | |
| 83854-002-10 | LACOSAMIDE | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 5 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lacosamide | LACOSAMIDE | Proficient Rx LP | 47ae2f1f-d135-4f4e-acc2-500c1afa7b8b | 2024-05-01 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Indoco Remedies Limited | ba337b2c-7c1f-4f7b-ba93-054f502400f3 | 2024-03-26 | Warnings, Adverse reactions | 809974 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Alembic Pharmaceuticals Inc. | 07b7b3f2-16a0-4deb-883b-10522676d966 | 2023-11-09 | Warnings, Adverse reactions | 563KS2PQY5 |
| LACOSAMIDE | LACOSAMIDE | Zydus Lifesciences Limited | 3bc84c70-bc1d-4a72-bbe7-86f32cd646d0 | 2023-10-03 | 809974 563KS2PQY5 | |
| Lacosamide | LACOSAMIDE | Tris Pharma Inc | 7f37f8b8-07d3-48c4-a0c4-7652b62a1ad9 | 2023-06-26 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Alembic Pharmaceuticals Limited | 46b98d5e-fdb6-483a-b022-8b1f0aa832c5 | 2023-01-27 | Warnings, Adverse reactions | 563KS2PQY5 |
| LACOSAMIDE | LACOSAMIDE | XLCare Pharmaceuticals Inc. | c7793da3-787b-4364-9192-7caab49066f1 | 2023-01-27 | Warnings, Adverse reactions | 809974 563KS2PQY5 |
| lacosamide | LACOSAMIDE | MSN LABORATORIES PRIVATE LIMITED | 0ae4e2d1-305d-4045-95da-cfe7c2d8b435 | 2022-04-21 | 563KS2PQY5 | |
| Lacosamide | LACOSAMIDE | Indoco Remedies Limited | 145b4fae-ce6d-43e8-a474-fcb9dff92a53 | 2022-03-09 | Warnings, Adverse reactions | 563KS2PQY5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.